Cite
Codon-Optimized and de novo-Synthesized E-Selectin/AAV2 Dose-Response Study for Vascular Regeneration Gene Therapy.
MLA
Voza, Francesca A., et al. “Codon-Optimized and de Novo-Synthesized E-Selectin/AAV2 Dose-Response Study for Vascular Regeneration Gene Therapy.” Annals of Surgery, vol. 280, no. 4, Oct. 2024, pp. 570–83. EBSCOhost, https://doi.org/10.1097/SLA.0000000000006436.
APA
Voza, F. A., Byrne, B. J., Ortiz, Y. Y., Li, Y., Le, N., Osafo, L., Ribieras, A. C., Shao, H., Huerta, C. T., Wei, Y., Falero-Diaz, G., Franco-Bravo, A., Lassance-Soares, R. M., Vazquez-Padron, R. I., Liu, Z.-J., & Velazquez, O. C. (2024). Codon-Optimized and de novo-Synthesized E-Selectin/AAV2 Dose-Response Study for Vascular Regeneration Gene Therapy. Annals of Surgery, 280(4), 570–583. https://doi.org/10.1097/SLA.0000000000006436
Chicago
Voza, Francesca A, Barry J Byrne, Yulexi Y Ortiz, Yan Li, Nga Le, Lucy Osafo, Antoine C Ribieras, et al. 2024. “Codon-Optimized and de Novo-Synthesized E-Selectin/AAV2 Dose-Response Study for Vascular Regeneration Gene Therapy.” Annals of Surgery 280 (4): 570–83. doi:10.1097/SLA.0000000000006436.